New FDA Protocols Will Soon Boost Inspection Consistency
This article was originally published in The Gold Sheet
Executive Summary
By the end of next year, new FDA protocols could bring more consistency from one inspection to the next and from one investigator to another.
You may also be interested in...
FDA's Kopcha Says New Inspection Protocols May Never Be Disclosed
Head of US FDA's Office of Pharmaceutical Quality says agency doesn't want pharmaceutical companies to know just how they will be inspected under the emerging standardized 'NIPP' approach, lest they use that knowledge to game the process.
FDA's Rollout of New Inspection Protocols May Begin Next Year
Despite great enthusiasm within the agency for a New Inspection Protocols Pilot Project, FDA officials are saying they don't expect to adopt the protocols for broader use in pharmaceutical facility preapproval and surveillance inspections until perhaps sometime in 2017. The protocols could make inspections more comparable – and could bring recognition to facilities that go beyond compliance.
‘Shadow’ Factory Challenges Continue For US FDA
Agency wants more information about API suppliers as it winds up case against KV Tech for hidden use of Dr. Reddy’s plant and seeks to find disappearing manufacturer of contaminated OTC eye drops.